Dewa Ayu Made Adnyaswari, Agung Wiwiek Indrayani, I Gusti Ayu Artini, Desak Ketut Ernawati, I Gusti Made Gede Surya Candra Trapika, Ni Putu Sriwidyani & I Gusti Kamasan Nyoman Arijana·Journal of Cancer and Tumor International·2025
Aims: Tumor Suppressor p53 is a frequent research target to further understand the mechanisms of cancer development and the pathogenesis of cancer. Arginase-1 may also be a potential prognosis predictor for HCC patients, and also be a new target for HCC treatment. This research a...
Open access
Research Article10.9734/jcti/2025/v15i1285
Dewa Ayu Made Adnyaswari, Agung Wiwiek Indrayani, IGusti Ayu Artini, Desak Ketut Ernawati, I. Gusti Made Gede Surya Candra Trapika, Ni Putu Sriwidyani & I Gusti Kamasan Nyoman Arijana·Journal of Cancer and Tumor International·2024
Aims: Hepatocellular carcinoma accounts for approximately 90% of all primary liver malignancies and poses a major global health challenge. The initiation of hepatocellular carcinoma (HCC) is marked by a progressive accumulation of molecular alterations, the origins of which remai...
Open access
Research Article10.9734/jcti/2024/v14i4269
Background: Drug metabolism is a crucial aspect of medical practice and pharmacology, involving the transformation of drugs by various bodily systems to create compounds that are more easily eliminated from the body. Sorafenib was reported as a useful adjuvant treatment in patien...
Open access
Research Article10.9734/jpri/2024/v36i27497